Name | 5-methyl-6-phenyl-5,6-dihydro-3,6-methano-1,5-benzodiazocine-2,4(1H,3H)-dione |
---|---|
Synonyms |
5-methyl-6-phenyl-5,6-dihydro-3,6-methano-1,5-benzodiazocine-2,4(1H,3H)-dione
12-Methyl-1-phenyl-8,12-diazatricyclo[8.2.1.0]trideca-2,4,6-triene-9,11-dione 3,6-Methano-1,5-benzodiazocine-2,4(1H,3H)-dione, 5,6-dihydro-5-methyl-6-phenyl- 5-Methyl-6-phenyl-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazocine-2,4-dione |
Description | BA 41899 is a purely calcium-sensitizing agent. BA 41899 is completely devoid of phosphodiesterase (PDE) III inhibitory activity or any other known inotropic mechanism. BA 41899 can be used for the research of cardiovascular diseases, such as congestive heart failure (CHF)[1]. |
---|---|
Related Catalog | |
In Vitro | BA 41899 (compound 6) 表现出包括 Ca2+ 敏化、正性肌力和负性变时作用在内的体外药理学特性[1]。 |
References |
Density | 1.273g/cm3 |
---|---|
Boiling Point | 539.4ºC at 760mmHg |
Molecular Formula | C18H16N2O2 |
Molecular Weight | 292.33200 |
Flash Point | 280ºC |
Exact Mass | 292.12100 |
PSA | 52.90000 |
LogP | 1.94 |
Vapour Pressure | 1.05E-11mmHg at 25°C |
Index of Refraction | 1.632 |